Exploiting immunogenic cell death to promote antitumor immunity
- 17 April 2026
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 47 (8) , 683-699
Abstract
No abstract availableKeywords
Funding Information
- European Research Council (19-051-ASP)
- Mark Foundation For Cancer Research (KWF-12539)
- National Natural Science Foundation of China (2023ZT10Y094)
- Key Technologies Research and Development Program (2024YFA0918400)
- National Health Commission of the People's Republic of China
- Health~Holland (LSH-TKI-LSHM20083)
- Sun Yat-sen University Cancer Center
- Ministerie van Volksgezondheid, Welzijn en Sport
- KWF Kankerbestrijding
- H2020 European Research Council (ERC-787925)
- National Key Research and Development Program of China (W2432050)
- National Key Research and Development Program of China (W2421020)
- National Key Research and Development Program of China (82372695)
- National Key Research and Development Program of China (82521103)
- National Key Research and Development Program of China (82303081)
- Basic and Applied Basic Research Foundation of Guangdong Province (YTP-SYSUCC-0055)
This publication has 110 references indexed in Scilit:
- Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer2025
- Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicityCell, 2024
- Cell deathCell, 2024
- Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8+ T cell exhaustion and curtails anti-PD-1 efficacyCell Reports, 2022
- Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cellsCancer Immunology, Immunotherapy, 2021
- Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathwayCell, 2021
- Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistanceCancer Cell, 2021
- Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock SyndromesCell, 2021
- Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint BlockadeCancer Cell, 2020
- Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor ImmunityCell Reports, 2016